Compounds > verapamil

verapamil and bedaquiline

verapamil has been researched along with bedaquiline in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (88.89)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Kumari, D; Perveen, S; Sharma, R; Singh, K1
Bishai, WR; Cohen, KA; Diarra, B; Gupta, S; Maiga, M; Winglee, K1
Andries, K; Coeck, N; de Jong, BC; Gevers, T; Koul, A; Lounis, N; Thys, K; Villellas, C; Vranckx, L1
Bishai, WR; Gupta, S; Tyagi, S1
Bishai, WR; Dooley, KE; Gupta, S; Srikrishna, G1
Almeida, DV; Barnes-Boyle, K; Li, SY; Lu, Y; Nuermberger, E; Peloquin, CA; Tasneen, R; Xu, J1
Chen, C; Dartois, V; Dick, T; Gardete, S; Jansen, RS; Rhee, KY; Shetty, A1
Fateh, A; Ghajavand, H; Kargarpour Kamakoli, M; Khanipour, S; Masoumi, M; Pourazar Dizaji, S; Rahimi Jamnani, F; Siadat, SD; Vaziri, F1
Daher, W; Herrmann, JL; Johansen, MD; Kremer, L; Raynaud, C; Roquet-Banères, F; Viljoen, A1

Reviews

1 review(s) available for verapamil and bedaquiline

ArticleYear
Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance.
    European journal of medicinal chemistry, 2022, Feb-05, Volume: 229

    Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin

2022

Other Studies

8 other study(ies) available for verapamil and bedaquiline

ArticleYear
Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:1

    Topics: Antitubercular Agents; Diarylquinolines; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Verapamil

2014
Acquired resistance of Mycobacterium tuberculosis to bedaquiline.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Animals; Antitubercular Agents; Bacterial Proteins; Base Sequence; Clofazimine; Diarylquinolines; Drug Resistance, Bacterial; Genes, Bacterial; Genetic Fitness; Humans; Mice; Microbial Sensitivity Tests; Models, Biological; Molecular Sequence Data; Mutation; Mycobacterium tuberculosis; Reserpine; Tuberculosis; Up-Regulation; Verapamil

2014
Verapamil increases the bactericidal activity of bedaquiline against Mycobacterium tuberculosis in a mouse model.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

    Topics: Animals; Antitubercular Agents; Calcium Channel Blockers; Diarylquinolines; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Tuberculosis, Pulmonary; Verapamil

2015
Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatment.
    Future microbiology, 2015, Volume: 10, Issue:8

    Topics: Antitubercular Agents; Arrhythmias, Cardiac; Diarylquinolines; Drug Therapy, Combination; Humans; Treatment Outcome; Tuberculosis; Verapamil

2015
Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:1

    Topics: Animals; Antitubercular Agents; Biological Availability; Calcium Channel Blockers; Clofazimine; Colony Count, Microbial; Diarylquinolines; Drug Resistance, Bacterial; Female; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis; Verapamil

2018
Verapamil Targets Membrane Energetics in Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:5

    Topics: Animals; Antitubercular Agents; Calcium Channel Blockers; Cell Membrane; Clofazimine; Diarylquinolines; Drug Synergism; Female; Humans; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Verapamil

2018
High Prevalence of Bedaquiline Resistance in Treatment-Naive Tuberculosis Patients and Verapamil Effectiveness.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:3

    Topics: Antitubercular Agents; Diarylquinolines; Drug Resistance, Bacterial; Humans; Iran; Membrane Transport Proteins; Mycobacterium tuberculosis; Retrospective Studies; Tuberculosis, Pulmonary; Verapamil

2019
Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:9

    Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Cell Line; Diarylquinolines; Drug Resistance, Bacterial; Drug Synergism; Humans; Macrophages; Microbial Sensitivity Tests; Mutation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Verapamil

2019